A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ₺8.366,41, with a 24-hour trading volume of ₺1,73B. The asset's market cap is ₺12,97T, after moving 1.30% in the last day.
Tokenized AstraZeneca PLC is trading at ₺4.244,82, with a tokenized market cap of ₺2,4B and a 24-hour trading volume of ₺28,84M. The tokenized asset has moved -8.58% in the past 24 hours.